Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > NY Providers > Oncologists

Dr. Michael Kaplitt, MD, PhD

Accepting New Patients

(Michael G. Kaplitt, MD, PhD - MSK Neurosurgeon)

(No ratings)

Specializes in: Oncology (Cancer Care) and Neurosurgery

Cornell University (1995)

Professional interests include: brain surgery, movement disorders, spinal cord stimulator, and more.

1305 York Avenue 9th Floor
New York, NY 10021

(212) 746-4966

Dr. Michael Kaplitt, MD, PhD is an oncologist in New York, NY specializing in oncology (cancer care) and neurosurgery. He graduated from Cornell University in 1995 and has 29 years of experience. Dr. Michael Kaplitt, MD, PhD is affiliated with NewYork-Presbyterian, Memorial Sloan Kettering Cancer Center and WEILL MEDICAL COLLEGE OF CORNELL.

Office Locations

Address:

1275 York Avenue Between 67th and 68th Streets
New York, NY 10065

Address:

1275 York Avenue New York Ny
City of New York, NY 10065

Address:

1305 York Avenue 9th Floor
New York, NY 10021

Some issues Dr. Michael Kaplitt, MD, PhD can help you with:

Deep Brain Stimulation (DBS)

Deep brain stimulation (DBS) is a procedure performed to help treat neurological conditions such as Parkinson's disease and epilepsy. Electrode leads are surgically implanted in the brain and connected to a device, called a neurostimulator (deep brain stimulator), that is placed underneath the skin (subcutaneously). The deep brain stimulator can send electrical signals through the electrodes to the brain to restore normal rhythms, or it can block electrical signals in specific areas of the brain to restore functioning. Although not a cure, DBS can treat symptoms of movement disorders such as pain and tremor when medication fails to work.

DBS surgery may be completed in one operating session, but it is more commonly performed in two parts. In the first stage of the procedure, the surgeon will map targets in the brain using CT or MRI imaging to determine where to place the electrodes. Then, by drilling holes into the skull, the surgeon will place the electrodes into specific areas in the brain. The holes will be closed, and patients will require 1-2 days to recover in the hospital. After about two weeks, patients will undergo another surgery to have the deep brain stimulator implanted. The stimulator is usually placed under the skin around the collarbone, chest, or abdomen, and it will be connected to the DBS electrodes through a subcutaneous wire. No component of the DBS system will be visible from outside. Following stimulator implantation, patients may need to recover in the hospital for 1-2 days.

Within 2-4 weeks of the operation, doctors will program the stimulator using a wireless device. Patients will work with their doctor to determine the most effective settings for the stimulator during follow-up visits. Patients will be given a handheld device so that they can turn the stimulator on or off and adjust its settings themselves. The stimulator may have a rechargeable battery, in which case patients will be given a charging unit. Stimulator batteries generally need to be replaced in 3-5 years.

Hydrocephalus

Normally, the brain is bathed in a liquid called cerebrospinal fluid. This fluid cushions and nurtures the brain cells as it flows around and through the brain. Sometimes, cerebrospinal fluid does not get reabsorbed into the body properly, or a blockage in the brain can stop it from flowing. This causes a buildup of pressure called hydrocephalus. This condition affects a wide range of people, but it is much more prevalent among infants and older adults. Left untreated, hydrocephalus can cause uncomfortable symptoms, such as headaches and blurred vision, and eventually may cause brain damage.

Hydrocephalus is most often treated with an implanted device called a shunt. A shunt is a long, thin tube that is used to drain excess fluid. One end is placed within the brain. The tube runs under the skin, along the neck behind the ear, and to another part of the body where the fluid can be reabsorbed. Most often this is the abdomen, but the chest or other areas can also be used. Shunts have a valve that allows doctors to monitor and control the pressure within the brain. Insertion of a shunt is a surgical procedure that takes one to two hours. Incisions are made in the head and the abdomen, and the shunt is threaded into place before the openings are stitched closed.

In cases where hydrocephalus is caused by a blockage, a procedure called endoscopic third ventriculostomy, or ETV, may be performed. During this procedure, a surgeon makes a dime-sized hole in the skull and uses a thin tube with a camera on the end (called an endoscope) to see inside the brain. The surgeon punctures a hole in the floor of the third ventricle, a fluid-filled space within the brain. The hole provides an opening for cerebrospinal fluid to flow around the blockage, normalizing pressure. The entire procedure usually takes less than an hour and patients can often go home the following day. ETV can provide a permanent and safe alternative to a shunt, but it is only useful for patients whose hydrocephalus is caused by a blockage.

Spinal Cord Stimulation (SCS)

If conservative treatment options and other spine surgeries have failed to provide someone pain relief, they may be a candidate for spinal cord stimulation. Spinal cord stimulation is a treatment for chronic back or leg pain. A spinal cord stimulator, which is surgically implanted underneath the skin (subcutaneously), can deliver electrical pulses to the area of pain. These pulses will reach the brain before the pain signals can, so instead of pain, patients will experience a tingling sensation.

To determine if spinal cord stimulation may benefit someone, they will first undergo a trial period. During this period, a temporary electrode lead is placed subcutaneously above the spinal cord, and it is connected to an external stimulator that they will carry with them. The procedure is typically completed within an hour, and patients may return home the same day. After a few days or weeks, the trial stimulator will be assessed for effectiveness. If the trial is unsuccessful, patients may undergo a second trial period, or the leads will be removed, and other treatment options will be considered. If, instead, a patient's pain is relieved during the trial, they will undergo surgery for implantation of a permanent stimulator and leads.

The components of a spinal cord stimulation system include the stimulator, the leads, and the wire that connects the two. Implantation of permanent leads may be percutaneous (through the skin) or involve a surgical incision. The spinal cord stimulator is implanted subcutaneously in the abdomen or buttock. The stimulator is battery-powered and may be rechargeable. If the battery is not rechargeable, it will last around 2-5 years, and a patient will need surgery to replace it.Their doctor will program the neurostimulator following the procedure.

After spinal cord stimulator surgery, patients may be released from the hospital the same day or the next one. In the weeks following the operation, patients will need to work with their doctors to find the optimal settings for their neurostimulator. Activities such as driving, twisting, bending, raising one's arms, sleeping on one's stomach, or lifting heavy objects should be limited.

In The News (see more mentions in the news)

“"Parkinson's patients have enormous difficulty maintaining balance on a steady floor," said Dr. Michael Kaplitt, a Parkinson's expert and neurological surgeon at NewYork-Presbyterian and Weill...”—"NYC man faces fines and has car auctioned off -- despite having a disabled permit", New York Post, July 2023

“Three researchers who were then at Rockefeller University - Dr. Michael G. Kaplitt, now professor of neurological surgery at Weill Cornell Medicine, Dr. Gandy, and Dr. Paul Greengard - published an...”—"A Promising Trial Targets a Genetic Risk for Alzheimer's", New York Times, December 2022

“"A lot of people, when they get to this stage, wouldn't feel motivated to go to this extreme," said Dr. Michael Kaplitt, an expert in Parkinson's disease at New York-Presbyterian/ Weill Cornell...”—"Catholic teachings on life, death hit home in case of pope / Pontiff's worsening condition could mean hard choices on accepting or delaying death", SFGATE, July 2018

doctor visit	57
implant surgery	19
neurostimulator replacement	19

**Gender**
Male	48
Female	58

**Ethnicity**
Non-Hispanic White	86
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	37
From 75 to 84	31
85 and over	13
Less than 65	25

Hypertension	58
High Cholesterol	66
Stroke	0
Ischemic Heart Disease	43
Depression	35
Chronic Kidney Disease	16
Asthma	0
Osteoperosis	15
Atrial Fibrilation	0
Heart Failure	18
Chronic Obstructive Pulmonary Disease	15
Diabetes	35
Dementia	31
Cancer	11

implant surgery	16
neurostimulator replacement	16

**Gender**
Male	27
Female	19

**Age**
From 65 to 74	26
From 75 to 84	0
85 and over	0
Less than 65	0

Hypertension	50
High Cholesterol	39
Stroke	0
Ischemic Heart Disease	33
Depression	26
Chronic Kidney Disease	0
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	0
Chronic Obstructive Pulmonary Disease	0
Diabetes	0
Dementia	28
Cancer	0

cerebrospinal fluid (CSF) shunt insertion	17
doctor visit	104
implant surgery	27
neurostimulator replacement	27
spinal procedures	12

**Gender**
Male	126
Female	104

**Ethnicity**
Non-Hispanic White	196
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	96
From 75 to 84	74
85 and over	22
Less than 65	38

Hypertension	63
High Cholesterol	57
Stroke	15
Ischemic Heart Disease	43
Depression	34
Chronic Kidney Disease	22
Asthma	12
Osteoperosis	0
Atrial Fibrilation	12
Heart Failure	24
Chronic Obstructive Pulmonary Disease	16
Diabetes	37
Dementia	29
Cancer	0

cerebrospinal fluid (CSF) shunt insertion	19
doctor visit	134
implant surgery	14
neurostimulator replacement	14

**Gender**
Male	86
Female	60

**Ethnicity**
Non-Hispanic White	117
Black	0
Hispanic	0
Asian	0
Other	12
Native American	0

**Age**
From 65 to 74	61
From 75 to 84	42
85 and over	24
Less than 65	19

Hypertension	66
High Cholesterol	54
Stroke	15
Ischemic Heart Disease	47
Depression	40
Chronic Kidney Disease	29
Asthma	17
Osteoperosis	11
Atrial Fibrilation	11
Heart Failure	23
Chronic Obstructive Pulmonary Disease	12
Diabetes	35
Dementia	34
Cancer	14

cerebrospinal fluid (CSF) shunt insertion	12
doctor visit	137
implant surgery	27
neurostimulator replacement	27

**Gender**
Male	97
Female	66

**Ethnicity**
Non-Hispanic White	140
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	65
From 75 to 84	65
85 and over	17
Less than 65	16

Hypertension	64
High Cholesterol	47
Stroke	8
Ischemic Heart Disease	42
Depression	40
Chronic Kidney Disease	29
Asthma	8
Osteoperosis	12
Atrial Fibrilation	0
Heart Failure	17
Chronic Obstructive Pulmonary Disease	10
Diabetes	37
Dementia	28
Cancer	9

cerebrospinal fluid (CSF) shunt insertion	11
cranial surgery	14
doctor visit	110
implant surgery	49
neurostimulator lead placement	14
neurostimulator replacement	49
spinal procedures	20

**Gender**
Male	93
Female	67

**Ethnicity**
Non-Hispanic White	132
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	62
From 75 to 84	56
85 and over	20
Less than 65	22

Hypertension	60
High Cholesterol	56
Stroke	9
Ischemic Heart Disease	41
Depression	36
Chronic Kidney Disease	23
Asthma	0
Osteoperosis	13
Atrial Fibrilation	8
Heart Failure	12
Chronic Obstructive Pulmonary Disease	10
Diabetes	33
Dementia	26
Cancer	11

cerebrospinal fluid (CSF) shunt insertion	12
cranial surgery	12
doctor visit	106
implant surgery	41
neurostimulator lead placement	12
neurostimulator replacement	41
spinal procedures	12

**Gender**
Male	75
Female	70

**Ethnicity**
Non-Hispanic White	118
Black	0
Hispanic	0
Asian	0
Other	14
Native American	0

**Age**
From 65 to 74	57
From 75 to 84	52
85 and over	14
Less than 65	22

Hypertension	61
High Cholesterol	59
Stroke	13
Ischemic Heart Disease	39
Depression	41
Chronic Kidney Disease	24
Asthma	0
Osteoperosis	12
Atrial Fibrilation	9
Heart Failure	17
Chronic Obstructive Pulmonary Disease	8
Diabetes	28
Dementia	26
Cancer	10

cranial surgery	12
doctor visit	93
implant surgery	32
neurostimulator lead placement	12
neurostimulator replacement	32
spinal procedures	11

**Gender**
Male	85
Female	54

**Ethnicity**
Non-Hispanic White	118
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	68
From 75 to 84	43
85 and over	12
Less than 65	16

Hypertension	64
High Cholesterol	66
Stroke	16
Ischemic Heart Disease	41
Depression	46
Chronic Kidney Disease	33
Asthma	9
Osteoperosis	14
Atrial Fibrilation	9
Heart Failure	17
Chronic Obstructive Pulmonary Disease	8
Diabetes	39
Dementia	26
Cancer	13

cerebrospinal fluid (CSF) shunt insertion	27
cranial surgery	32
doctor visit	226
hospital care	10
implant surgery	59
inpatient care	10
neurostimulator lead placement	32
neurostimulator replacement	59

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Michael Kaplitt, MD, PhD for Medicare patients.

The highest averages for the top procedures that Dr. Michael Kaplitt, MD, PhD treated as an oncologist in New York, NY were neurostimulator replacement, implant surgery, neurostimulator lead placement and cranial surgery.

cranial surgery	17
doctor visit	122
hospital care	10
implant surgery	32
inpatient care	10
neurostimulator lead placement	17
neurostimulator replacement	32
spinal procedures	13

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Michael Kaplitt, MD, PhD.

**Gender**
Male	63
Female	49

**Ethnicity**
Black / African American	0
Asian / Pacific Islander	0
Non-Hispanic White	90
Native American / Alaskan Native	0
Hispanic	0
Other	2

**Age**
75 to 84	36
85 and over	12
Less than 65	15
65 to 74	47

Average of Total of Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Michael Kaplitt, MD, PhD treated were hypertension, high cholesterol, ischemic heart disease and depression.

Hypertension	48
High Cholesterol	44
Stroke	7
Ischemic Heart Disease	32
Depression	29
Chronic Kidney Disease	17
Asthma	4
Osteoporosis	7
Heart Failure	12
Chronic Obstructive Pulmonary Disease	7
Diabetes	24
Atrial Fibrillation	4
Cancer	6
Dementia	22

Education & Training

Dr. Michael Kaplitt, MD, PhD graduated from Cornell University in 1995. He completed residency at New York Hospital. He is certified by the Surgery, Neurological and has a state license in New York.

Medical School: Cornell University (1995)

Residency: New York Hospital (2000)

Board Certification: Surgery, Neurological

Licensed In: New York

Affiliations & Hospitals

Dr. Michael Kaplitt, MD, PhD is associated with these hospitals and organizations:

NewYork-Presbyterian

Memorial Sloan Kettering Cancer Center

WEILL MEDICAL COLLEGE OF CORNELL

Insurance Information

Please note: Insurance information may change at any time, and the provider may accept your insurance plan even if it is not listed below. Please contact the provider's office to confirm that your insurance is accepted.

Dr. Michael Kaplitt, MD, PhD appears to accept the following insurance providers: Qualcare, Oscar, Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO), Multiplan/Beech Street/PHCS, Connecticare, Emblem Medicare Advantage, MVP, Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23), Aetna, Magnacare, United Healthcare, Oxford, Husky CT Medicaid, Cigna, Fidelis Managed Medicaid & HARP, Tricare, Healthfirst, Healthsmart, Healthfirst Medicare Advantage, First Health, Carrum Health, Non-Participating Plans with Out of Network Benefits, Blue Cross Blue Shield New York, UMR, World Trade Center Health Program (WTC), Blue Cross Health Plus, Blue Cross Blue Shield states outside of NY/NJ, Medicare Part A&B (traditional Medicare), Blue Cross Blue Shield Federal Employee Program, Empire Essential, Group Health Incorporated (GHI), Health Insurance Plan of New York (HIP), Beech Street, Empire BlueCross BlueShield, Ingrese su proveedor de seguros, Remove item, VNSNY CHOICE, Programa de Salud World Trade Center (WTC), Estados de Blue Cross Blue Shield fuera de NY/NJ, Medicare Parte A y Parte B (Medicare tradicional), Planes no participantes con prestaciones fuera de la red, Blue Cross Blue Shield Nueva York and Programa de empleados federales Blue Cross Blue Shield.

Insurance Accepted by Provider includes:

According to our sources, Dr. Michael Kaplitt, MD, PhD accepts the following insurance providers:

Qualcare

Oscar

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Multiplan/Beech Street/PHCS

Connecticare

Emblem Medicare Advantage

MVP

Aetna Medicare Advantage (City of NY retirees only, starting 9/1/23)

Aetna

Magnacare

United Healthcare

Oxford

Husky CT Medicaid

Cigna

Fidelis Managed Medicaid & HARP

Tricare

Healthfirst

Healthsmart

Healthfirst Medicare Advantage

First Health

Carrum Health

Non-Participating Plans with Out of Network Benefits

Blue Cross Blue Shield New York

UMR

World Trade Center Health Program (WTC)

Blue Cross Health Plus

Blue Cross Blue Shield states outside of NY/NJ

Medicare Part A&B (traditional Medicare)

Blue Cross Blue Shield Federal Employee Program

Empire Essential

Group Health Incorporated (GHI)

Health Insurance Plan of New York (HIP)

Beech Street

Empire BlueCross BlueShield

Ingrese su proveedor de seguros

Remove item

VNSNY CHOICE

Programa de Salud World Trade Center (WTC)

Estados de Blue Cross Blue Shield fuera de NY/NJ

Medicare Parte A y Parte B (Medicare tradicional)

Planes no participantes con prestaciones fuera de la red

Blue Cross Blue Shield Nueva York

Programa de empleados federales Blue Cross Blue Shield

Show More

Ratings & Reviews

Dr. Michael Kaplitt, MD, PhD does not have any reviews yet, be the first to leave a review of Dr. Michael Kaplitt, MD, PhD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Michael Kaplitt, MD, PhD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
InSightec,Inc	$389 Exablate $389
Abbott Laboratories	$223 Deep Brain Stimulation $167	Proclaim Family of SCS IPGs $56
Medtronic USA, Inc.	$213 PIPELINE $151	ACTIVA $63
DePuy Orthopaedics Inc.	$152 Cranial ReconstructionFixation $152
Medtronic Sofamor Danek USA, Inc.	$120 Deep Brain Neurostimulation $120
Other	$125 BioSurgery - FLOSEAL $80	$45

**Types of Payments**
Food and Beverage	$832
Travel and Lodging	$389

Research Payments

Dr. Michael Kaplitt, MD, PhD has received 10 research payments totaling $473,121.

Biography

Dr. Michael Kaplitt practices oncology (cancer care) and neurosurgery. He studied medicine at Weill Cornell Medical College. For his residency, Dr. Kaplitt trained at New York-Presbyterian Hospital and a hospital affiliated with Weill Cornell Medical College. Dr. Kaplitt is professionally affiliated with Memorial Sloan Kettering Cancer Center and NewYork-Presbyterian. According to Yext, he is currently accepting new patients at his office in New York, NY.

Select Year:

Dr. Michael Kaplitt, MD, PhD

Office Locations

Some issues Dr. Michael Kaplitt, MD, PhD can help you with:

In The News (see more mentions in the news)

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

2013 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2013

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

2014 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2014

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

2015 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2015

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

2016 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2016

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

2017 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2017

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

2018 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2018

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

2019 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2019

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

2020 Medicare Patient Data

Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD in 2020

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

Average Medicare Procedure Volume From 2013 - 2021

Average Medicare Patient Data From 2013 - 2021

Average of Total of Conditions of Medicare patients treated by Dr. Michael Kaplitt, MD, PhD From 2013 - 2021

Education & Training

Affiliations & Hospitals

Insurance Information

Ratings & Reviews

General Payments

Research Payments

Biography

Oncologists in Nearby Locations

Other Providers in New York, NY